Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns study

PLoS One. 2015 Jun 1;10(6):e0128652. doi: 10.1371/journal.pone.0128652. eCollection 2015.

Abstract

Background: For hemodialysis (HD) patients, many risk factors for death are associated with each other intricately. However, they are often considered separately in clinical settings. We evaluated the maintenance HD patients' risk of death within one year from multiple risk factors simultaneously considering their interrelationships using a novel index (survival index, SI) for HD patients in the United States developed using data from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Methods: We analyzed data from 3899 and 3765 patients to develop and validate SI, respectively. To predict death within one year, candidate models were developed using logistic regression models. The final model was determined by comparing the accuracy among the models for the prediction of deaths.

Results: The model included age; body mass index; serum creatinine, albumin, total cholesterol and phosphorus levels; history of cardiovascular diseases; and arteriovenous fistula use. SI showed a higher accuracy in predicting death (c-statistic, 0.739) than geriatric nutritional risk index (0.647) and serum albumin level (0.637). The probability of death predicted on the basis of SI matched the observed number of deaths. Cox proportional hazard models for time-dependent SI showed that patients with low SI had a higher risk of death than patients with high SI [reference, Group 4 (26.1≤SI)]; Group 1 (SI<12.7), adjusted hazard ratio, 7.97 (95% CI, 5.02, 12.65); Group 2 (12.7≤SI<19.0), 3.18 (95% CI, 1.96, 5.16); Group 3 (19.0≤SI<26.1), 2.20 (95% CI, 1.33, 3.66).

Conclusion: Results of this study suggest that the simultaneous evaluation of multiple risk factors can more accurately assess patients' prognosis and identify patients at an increased risk of death than single factors.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Mass Index
  • Cholesterol / blood
  • Cohort Studies
  • Creatinine / blood
  • Female
  • Humans
  • Kidney Failure, Chronic / mortality*
  • Logistic Models
  • Male
  • Middle Aged
  • Nutritional Status / physiology
  • Phosphorus / blood
  • Prognosis
  • Renal Dialysis / adverse effects*
  • Risk Factors
  • Serum Albumin / metabolism
  • United States

Substances

  • Serum Albumin
  • Phosphorus
  • Cholesterol
  • Creatinine

Grants and funding

The DOPPS is administered by Arbor Research Collaborative for Health. The DOPPS Program has been supported by scientific research grants from Amgen (since 1996), Kyowa Hakko Kirin (since 1999, in Japan), Sanofi Renal (since 2009), AbbVie (since 2009), Baxter (since 2011), and Vifor Fresenius Renal Pharma (since 2011), with the shared mission of providing a strong scientific basis for the identification of dialysis and CKD practices that are most associated with improved patient survival and quality of life. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. All support has been provided without restrictions on publications.